secwatch / observer
8-K filed January 20, 2023, 6:59 PM ET ticker SDEV CIK 0001389545
leadership confidence high sentiment neutral materiality 0.55

CFO Andrew Jones resigns; Controller Tommy Law named interim CFO

Stablecoin Development Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Tommy Law

Interim Chief Financial Officer and Treasurer
SDEV · Stablecoin Development Corp
Effective
2023-02-16
Filed
January 20, 2023, 6:59 PM ET
Due to Mr. Jones’ departure, the Board of Directors of the Company appointed Tommy Law, currently the Company’s Controller, as the Company’s Interim Chief Financial Officer and Treasurer, effective February 16, 2023, until a permanent replacement can be found.
Departed

Andrew Jones

Chief Financial Officer and Treasurer
SDEV · Stablecoin Development Corp
Effective
2023-02-15
Successor
Tommy Law
Filed
January 20, 2023, 6:59 PM ET
On January 19, 2023, Andrew Jones advised NovaBay Pharmaceuticals, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company’s Chief Financial Officer and Treasurer effective as of February 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tommy Law was appointed as Interim Chief Financial Officer and Treasurer at Stablecoin Development Corp.

Action
appointed
Role
Interim Chief Financial Officer and Treasurer
Exact text from the filing
Due to Mr. Jones’ departure, the Board of Directors of the Company appointed Tommy Law, currently the Company’s Controller, as the Company’s Interim Chief Financial Officer and Treasurer, effective February 16, 2023, until a permanent replacement can be found.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Jones resigned as Chief Financial Officer and Treasurer at Stablecoin Development Corp.

Action
resigned
Role
Chief Financial Officer and Treasurer
Exact text from the filing
On January 19, 2023, Andrew Jones advised NovaBay Pharmaceuticals, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company’s Chief Financial Officer and Treasurer effective as of February 15, 2023.
View on SEC.gov

Stablecoin Development Corp filing history →

Source: SEC EDGAR
accession 0001437749-23-001446
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.